Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia.
Zhang C, He J, Liu L, Wang J, Wang S, Liu L, Ge J, Gao L, Gao L, Kong P, Liu Y, Liu J, Han Y, Zhang Y, Sun Z, Ye X, Yin W, Sersch M, Shen L, Cao WW, Zhang X.
Zhang C, et al. Among authors: han y.
Blood Cancer J. 2022 Jun 24;12(6):96. doi: 10.1038/s41408-022-00688-4.
Blood Cancer J. 2022.
PMID: 35750687
Free PMC article.